Lenvatinib
7902-012
Phase 3 small_molecule completed
Quick answer
Lenvatinib for Carcinoma, Hepatocellular is a Phase 3 program (small_molecule) at Merck KGaA, Darmstadt, Germany with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck KGaA, Darmstadt, Germany
- Indication
- Carcinoma, Hepatocellular
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed